# Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery

Study · id `cardio:ct-nct07740330` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07740330](<https://clinicaltrials.gov/study/NCT07740330>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07740330

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT07740330. Randomized; quadruple masking; primary purpose prevention. Start 2026-10 (anticipated); primary completion 2028-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT07740330, source copy `cardio:ctgov-nct07740330-2026-07-31`, retrieved 2026-10-26)
- Planned start: 2026-10 (anticipated) (ClinicalTrials.gov record NCT07740330, source copy `cardio:ctgov-nct07740330-2026-07-31`, retrieved 2026-10-26)
- Primary completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT07740330, source copy `cardio:ctgov-nct07740330-2026-07-31`, retrieved 2026-10-26)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07740330, source copy `cardio:ctgov-nct07740330-2026-07-31`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT07740330, source copy `cardio:ctgov-nct07740330-2026-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07740330-2026-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery
- Acronym: TRANSCAB
- Condition: Coronary Artery Disease
- Condition: Perioperative Bleeding
- Intervention (Drug): Oral tranexamic acid
- Intervention (Drug): Exacyl®
- Intervention (Drug): Intravenous placebo
- Lead sponsor: Clinique Saint-Luc
- Lead sponsor class: NETWORK

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: 2519c4c29e4927575b65025ce948a6b190fef58a89d805acbff79738774b055f
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
